Cargando…
Teriparatide Treatment for Hypercalcemia Associated With Adynamic Bone Disease
Hypercalcemia most often results from primary hyperparathyroidism and malignancy. Adynamic bone disease (ABD) is a form of renal osteodystrophy characterized by reduced bone turnover, which can limit the ability of bone to release or store calcium, potentially leading to low, normal, or high serum c...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659444/ https://www.ncbi.nlm.nih.gov/pubmed/31372586 http://dx.doi.org/10.1002/jbm4.10176 |